WhiteOak Capital Pharma and Healthcare Fund Regular Growth | WhiteOak Capital Pharma and Healthcare Fund NAV Today [15.45], Performance & History

Equity Sectoral Thematic Regular Growth

Regular

Direct

2 Year Absolute Returns

46.30% ↑

NAV (₹) on 19 Jun 2026

15.45

1 Day NAV Change

0.90%

Risk Level

Very High Risk

Rating

WhiteOak Capital Pharma and Healthcare Fund is a Equity mutual fund categorized under Sector, offered by WhiteOak Capital Asset Management Ltd.. Launched on 16 Jan 2024, investors can start with a ... Read more

NAV History

Fund Details

Min. SIP Amount

₹100

Inception Date

16 Jan 2024

Min. Lumpsum Amount

₹ 500

Fund Age

2 Yrs

AUM

₹ 664.02 Cr.

Benchmark

BSE Healthcare Total Return

Expense Ratio

2.42%

Scheme Type

Open Ended

Exit Load

Nil%

Asset Allocation

AUM

₹ 664.02 Cr

Equity

465.88%

Debt

15.52%

Money Market & Cash

14.25%

Other Assets & Liabilities

4.48%

Sector Holdings

Sectors	Weightage
Pharmaceuticals	58.52%
Hospitals & Medical Services	28.10%
Treps/Reverse Repo	3.94%
Treasury Bill	2.07%
Others - Not Mentioned	1.94%
Plastics - Plastic & Plastic Products	1.75%
Chemicals - Speciality	1.32%
Chemicals - Others	1.17%
Medical Equipment & Accessories	0.90%
Net Receivables/(Payables)	0.29%

See All

Stock Holdings

Name	Weightage	Value (in Cr.)	Sector
Sun Pharmaceutical Industries Limited	9.56%	₹ 63.50	Pharmaceuticals
JB Chemicals & Pharmaceuticals Limited	6.80%	₹ 45.16	Pharmaceuticals
Apollo Hospitals Enterprise Limited	4.83%	₹ 32.08	Hospitals & Medical Services
Laurus Labs Limited	4.43%	₹ 29.38	Pharmaceuticals
Clearing Corporation of India Ltd	3.94%	₹ 26.14	Others
Fortis Healthcare Limited	3.92%	₹ 26.05	Hospitals & Medical Services
Krishna Institute Of Medical Sciences Limited	3.44%	₹ 22.82	Hospitals & Medical Services
Divi's Laboratories Limited	3.29%	₹ 21.86	Pharmaceuticals
Sai Life Sciences Limited	3.17%	₹ 21.07	Pharmaceuticals
Max Healthcare Institute Limited	2.83%	₹ 18.77	Hospitals & Medical Services
Aurobindo Pharma Limited	2.62%	₹ 17.37	Pharmaceuticals
Neuland Laboratories Limited	2.53%	₹ 16.82	Pharmaceuticals
Acutaas Chemicals Limited	2.46%	₹ 16.35	Pharmaceuticals
Corona Remedies Limited	2.32%	₹ 15.43	Pharmaceuticals
Dr. Lal Path Labs Limited	2.11%	₹ 14.01	Hospitals & Medical Services
Thyrocare Technologies Limited	2.06%	₹ 13.65	Hospitals & Medical Services
Gland Pharma Limited	1.99%	₹ 13.24	Pharmaceuticals
Narayana Hrudayalaya Limited	1.88%	₹ 12.50	Hospitals & Medical Services
Aster DM Healthcare Limited	1.80%	₹ 11.94	Hospitals & Medical Services
Shaily Engineering Plastics Limited	1.75%	₹ 11.61	Plastics - Plastic & Plastic Products
Ajanta Pharma Limited	1.68%	₹ 11.14	Pharmaceuticals
Zydus Lifesciences Limited	1.61%	₹ 10.66	Pharmaceuticals
Rainbow Childrens Medicare Limited	1.59%	₹ 10.55	Hospitals & Medical Services
182 Days Tbill (MD 06/08/2026)	1.49%	₹ 9.90	Others - Not Mentioned
Strides Pharma Science Limited	1.42%	₹ 9.40	Pharmaceuticals
Procter & Gamble Health Limited	1.41%	₹ 9.36	Pharmaceuticals
Glenmark Pharmaceuticals Limited	1.35%	₹ 8.97	Pharmaceuticals
Vijaya Diagnostic Centre Limited	1.31%	₹ 8.72	Hospitals & Medical Services
Granules India Limited	1.30%	₹ 8.60	Pharmaceuticals
Onesource Specialty Pharma Limited	1.26%	₹ 8.37	Pharmaceuticals
Navin Fluorine International Limited	1.17%	₹ 7.79	Chemicals - Others
Aether Industries Limited	1.13%	₹ 7.50	Chemicals - Speciality
Pfizer Limited	1.10%	₹ 7.33	Pharmaceuticals
Innova Captab Limited	1.09%	₹ 7.24	Pharmaceuticals
Kovai Medical Center and Hospital Limited	1.07%	₹ 7.13	Hospitals & Medical Services
Anthem Biosciences Limited	0.94%	₹ 6.22	Pharmaceuticals
Supriya Lifescience Limited	0.92%	₹ 6.13	Pharmaceuticals
IPCA Laboratories Limited	0.92%	₹ 6.13	Pharmaceuticals
Poly Medicure Limited	0.90%	₹ 5.97	Medical Equipment & Accessories
Senores Pharmaceuticals Limited	0.81%	₹ 5.35	Pharmaceuticals
Aarti Pharmalabs Limited	0.74%	₹ 4.95	Pharmaceuticals
Cipla Limited	0.69%	₹ 4.56	Pharmaceuticals
Jupiter Life Line Hospitals Limited	0.66%	₹ 4.36	Hospitals & Medical Services
91 Days Tbill (MD 13/08/2026)	0.60%	₹ 3.96	Others
91 Days Tbill (MD 06/08/2026)	0.60%	₹ 3.96	Others
91 Days Tbill (MD 30/07/2026)	0.60%	₹ 3.97	Others
Nephrocare Health Services Ltd	0.60%	₹ 4	Hospitals & Medical Services
Abbott India Limited	0.58%	₹ 3.83	Pharmaceuticals
Sudeep Pharma Limited	0.50%	₹ 3.30	Pharmaceuticals
Zota Health Care Limited	0.49%	₹ 3.24	Pharmaceuticals
182 Days Tbill (MD 11/06/2026)	0.30%	₹ 2	Others - Not Mentioned
Net Receivables / (Payables)	0.29%	₹ 2.07	Others
Cohance Lifesciences Limited	0.27%	₹ 1.80	Pharmaceuticals
Orchid Pharma Limited	0.27%	₹ 1.77	Pharmaceuticals
Tatva Chintan Pharma Chem Limited	0.19%	₹ 1.27	Chemicals - Speciality
91 Days Tbill (MD 04/06/2026)	0.15%	₹ 1	Others
91 Days Tbill (MD 20/08/2026)	0.12%	₹ 0.79	Others
182 Days Tbill (MD 04/06/2026)	0.12%	₹ 0.80	Others - Not Mentioned
182 Days Tbill (MD 18/06/2026)	0.03%	₹ 0.20	Others - Not Mentioned

See All

Returns

	Annualised returns
	9M	1Y	2Y	3Y
Fund returns	9.21%	18.64%	20.95%	-
Category returns	1.21%	5.68%	6.27%	22.53%

Fund Objective

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. However, there ... Read more

AMC Details

Name

WhiteOak Capital Asset Management Ltd.

Date of Incorporation

03 Jul 2018

CEO

Mr. Aashish P Somaiyaa

CIO

Mr. Ramesh Mantri

Type

Pvt.Sector-Indian

Address

Unit No. B4, 6th Floor, Cnergy, Appasaheb Marathe Marg, Prabhadevi, Mumbai, Maharashtra, India - 400025

Website

https://mf.whiteoakamc.com

[email protected]

Top Funds from Equity - Sectoral/Thematic

Scheme Name	NAV	Returns 1Y 3Y 5Y			AUM (Cr)	Expense Ratio	Risk Meter
Nippon India Taiwan Equity fund - Direct Plan Sector Direct	₹39.90	202.92%	342.40%	0.00%	₹1,256	0.85%	Very High
Nippon India Taiwan Equity fund - Direct Plan Sector Direct	₹39.90	202.92%	342.40%	0.00%	₹1,256	0.85%	Very High
Nippon India Taiwan Equity fund - Direct Plan Sector Direct	₹39.90	202.92%	342.40%	0.00%	₹1,256	0.85%	Very High
Nippon India Taiwan Equity Fund Sector Regular	₹37.37	198.79%	324.40%	0.00%	₹1,256	2.15%	Very High
Nippon India Taiwan Equity Fund Sector Regular	₹37.37	198.79%	324.40%	0.00%	₹1,256	2.15%	Very High
Nippon India Taiwan Equity Fund Sector Regular	₹37.37	198.79%	324.40%	0.00%	₹1,256	2.15%	Very High
HDFC Defence Fund - Direct Plan Sector Direct	₹30.47	18.71%	201.11%	0.00%	₹9,724	0.83%	Very High
HDFC Defence Fund - Direct Plan Sector Direct	₹30.47	18.71%	201.11%	0.00%	₹9,724	0.83%	Very High
HDFC Defence Fund - Direct Plan Sector Direct	₹30.47	18.71%	201.11%	0.00%	₹9,724	0.83%	Very High
HDFC Defence Fund Sector Regular	₹29.45	17.51%	191.18%	0.00%	₹9,724	1.75%	Very High

Top Funds from WhiteOak Capital Asset Management Ltd.

Scheme Name	NAV	Returns 1Y 3Y 5Y			AUM (Cr)	Expense Ratio	Risk Meter
WhiteOak Capital Mid Cap Fund - Direct Plan Diversified Direct	₹22.48	15.21%	96.60%	0.00%	₹5,732	0.60%	Very High
WhiteOak Capital Mid Cap Fund - Direct Plan Diversified Direct	₹22.48	15.21%	96.60%	0.00%	₹5,732	0.60%	Very High
WhiteOak Capital Mid Cap Fund - Direct Plan Diversified Direct	₹22.48	15.21%	96.60%	0.00%	₹5,732	0.60%	Very High
WhiteOak Capital Mid Cap Fund Diversified Regular	₹21.21	13.69%	88.04%	0.00%	₹5,732	1.86%	Very High
WhiteOak Capital Mid Cap Fund Diversified Regular	₹21.21	13.69%	88.04%	0.00%	₹5,732	1.86%	Very High
WhiteOak Capital Mid Cap Fund Diversified Regular	₹21.21	13.69%	88.04%	0.00%	₹5,732	1.86%	Very High
WhiteOak Capital ELSS Tax Saver Fund - Direct Plan ELSS Direct	₹18.53	3.77%	67.01%	0.00%	₹456	0.81%	Very High
WhiteOak Capital ELSS Tax Saver Fund - Direct Plan ELSS Direct	₹18.53	3.77%	67.01%	0.00%	₹456	0.81%	Very High
WhiteOak Capital ELSS Tax Saver Fund - Direct Plan ELSS Direct	₹18.53	3.77%	67.01%	0.00%	₹456	0.81%	Very High
WhiteOak Capital Flexi Cap Fund - Direct Plan Diversified Direct	₹18.52	4.86%	61.77%	0.00%	₹8,136	0.54%	Very High

FAQs

What is the current NAV of WhiteOak Capital Pharma and Healthcare Fund Regular Growth?

The current Net Asset Value (NAV) of WhiteOak Capital Pharma and Healthcare Fund Regular Growth is ₹15.45 as of 19 Jun 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.

What is the fund size (AUM) of WhiteOak Capital Pharma and Healthcare Fund Regular Growth?

The Assets Under Management (AUM) of WhiteOak Capital Pharma and Healthcare Fund Regular Growth is ₹664.02 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.

What are the historical returns of WhiteOak Capital Pharma and Healthcare Fund Regular Growth?

WhiteOak Capital Pharma and Healthcare Fund Regular Growth has delivered returns of 18.64% (1 Year), 0.00% (3 Year), 0.00% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.

What is the risk level of WhiteOak Capital Pharma and Healthcare Fund Regular Growth?

WhiteOak Capital Pharma and Healthcare Fund Regular Growth has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.

What is the minimum investment amount for WhiteOak Capital Pharma and Healthcare Fund Regular Growth?

The minimum lumpsum investment required for WhiteOak Capital Pharma and Healthcare Fund Regular Growth is ₹500. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹100, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article